Latest issue of Schering research magazine “livingbridges” published

Berlin, July 27, 2006

What is innovation? In its latest issue, the Schering research magazine “livingbridges” gets to the bottom of the question: How is something new created? Is something new automatically an innovation? Can you plan innovation or does coincidence also play a role? What social, political and regulatory environment is needed so that innovation can flourish?

In the latest issue of “livingbridges” the following topics are dealt with in detail:

• Contraception: In 1964 Schering marketed the first contraceptive and thus changed the role of the woman in society. Since then the pill has undergone countless innovation cycles and developed into a product that can do much more than just prevent unwanted pregnancies.
• Morbus Crohn: Two researchers from the US stun their colleagues with their innovative therapy.
• “Knowledge creates art”: How artists and researchers draw ever closer.
• “Quite natural – curiosity”: On the trail of a characteristic which is not only found in humans.
• “The human factor”: The role coincidence plays in research.
Get a glance at the new issue and order online for free: www.livingbridges.com (available from July 28th onwards)

The Schering research magazine “livingbridges” deals with relevant current areas of research and science trough reportages, interviews and analysis. In addition, stunning pictures are published in the magazine.

“livingbridges” is published in German and English with a circulation of altogether 30.000 copies.



Schering AG is a research-based pharmaceutical company. Its activities are focused on four business areas: Gynecology&Andrology, Oncology, Diagnostic Imaging as well as Specialized Therapeutics for disabling diseases. As a global player with innovative products, Schering AG aims for leading positions in specialized markets worldwide. With in-house R&D and supported by an excellent global network of external partners, Schering AG is securing a promising product pipeline. Using new ideas, Schering AG aims to make a recognized contribution to medical progress and strives to improve the quality of life: making medicine work.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, Including but not limited to statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and Schering AG’s plans and objectives to differ materially from those expressed or implied in the forward-looking statements. Certain factors that may cause such differences are discussed in our Form 20-F and Form 6-K reports filed with the U.S. Securities and Exchange Commission. Schering AG undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.

Contact Information

Frank Richtersmeier

Corporate Communication

Schering AG

Contact via E-mail